Binkui Li

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 18, 2026
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.

|Dec 08, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.

Zefeng Du, Zhicheng Lai, Yexing Huang

|Sep 18, 2025
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma.

Yichuan Yuan, Yi Niu, Zhenkun Huang

|May 08, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.

Liang Qiao, Wei He, Guoying Wang

|Aug 14, 2023
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma.

Keren Li, Yi Niu, Kai Li

|Dec 08, 2022
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma?

Wei He, Binkui Li, Yunfei Yuan

Pageof 2

Frequent Collaborators

6 joint publications

Yunfei Yuan

3 joint publications

Wei He

3 joint publications

Yichuan Yuan

2 joint publications

Chenwei Wang